Filtered By:
Source: Drugs.com - Pharma News

This page shows you your search results in order of date.

Order by Relevance | Date

Total 90 results found since Jan 2013.

Cases of Pediatric Therapeutic Errors Related to ADHD Meds on the Rise
MONDAY, Sept. 18, 2023 -- From 2000 to 2021, there was an almost 300 percent increase in the annual frequency of cases of pediatric out-of-hospital therapeutic errors related to attention-deficit/hyperactivity disorder (ADHD) medications, according...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

ADHD Is Independent Risk Factor for Psychiatric Disorders
THURSDAY, Sept. 7, 2023 -- Attention-deficit hyperactivity disorder (ADHD) is an independent risk factor for certain psychiatric disorders, including anorexia nervosa and major depressive disorder, according to a study published online Sept. 5 in...
Source: Drugs.com - Pharma News - September 7, 2023 Category: Pharmaceuticals Source Type: news

Output of ADHD Meds Needs Boosting
WEDNESDAY, Aug. 2, 2023 -- While demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production of the medications. Officials from both the U.S....
Source: Drugs.com - Pharma News - August 2, 2023 Category: Pharmaceuticals Source Type: news

Amid Shortages, Federal Agencies Ask Drugmakers to Boost Output of ADHD Meds
WEDNESDAY, Aug. 2, 2023 -- While demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production of the medications. Officials from both the U.S....
Source: Drugs.com - Pharma News - August 2, 2023 Category: Pharmaceuticals Source Type: news

Stimulant Treatment for Childhood ADHD Not Linked to Substance Use
TUESDAY, July 11, 2023 -- For children with attention-deficit/hyperactivity disorder (ADHD), stimulant treatment is not associated with later frequent substance use by adolescents and young adults, according to a study published online July 5 in...
Source: Drugs.com - Pharma News - July 11, 2023 Category: Pharmaceuticals Source Type: news

Stop-Signal Task May Aid Assessment of Adult ADHD
FRIDAY, June 16, 2023 -- The stop-signal task may be valuable for assessing inhibitory control deficits in adult attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published online June 10 in...
Source: Drugs.com - Pharma News - June 16, 2023 Category: Pharmaceuticals Source Type: news

Most Children With ADHD Are Not Receiving Medications
FRIDAY, April 28, 2023 -- Most children with parent-reported attention-deficit/hyperactivity disorder (ADHD) are not receiving medications and have never received outpatient mental health care, according to a study published online April 28 in JAMA...
Source: Drugs.com - Pharma News - April 28, 2023 Category: Pharmaceuticals Source Type: news

ADHD Tied to Higher Fracture Risk in Children
MONDAY, April 24, 2023 -- Children with attention-deficit/hyperactivity disorder (ADHD) have higher risk of fractures than matched children without ADHD, according to a study published April 1 in the European Journal of Pediatrics. Tomer...
Source: Drugs.com - Pharma News - April 24, 2023 Category: Pharmaceuticals Source Type: news

Stimulant Misuse Rates Higher in Schools With More Students With Prescriptions
TUESDAY, April 18, 2023 -- Risk for nonmedical use of prescription stimulants (NUPS) is higher for schools with a greater proportion of the student body that uses stimulant therapy for attention-deficit/hyperactivity disorder (ADHD), according to a...
Source: Drugs.com - Pharma News - April 18, 2023 Category: Pharmaceuticals Source Type: news

Telehealth Prescriptions for Painkillers, ADHD Drugs Back to Old Rules
MONDAY, Feb. 27, 2023 -- Federal officials plan to tighten access to drugs that have the potential for abuse by reinstating federal prescribing requirements that were loosened during the pandemic. The Biden administration will require that patients...
Source: Drugs.com - Pharma News - February 27, 2023 Category: Pharmaceuticals Source Type: news

ADHD Med Exposure in Utero Not Tied to Long-Term Impact in Offspring
FRIDAY, Feb. 24, 2023 -- Neurodevelopment and growth in offspring is not negatively impacted by prenatal exposure to attention-deficit/hyperactivity disorder (ADHD) medication, according to a study published online Feb. 9 in Molecular...
Source: Drugs.com - Pharma News - February 24, 2023 Category: Pharmaceuticals Source Type: news

No Significant Association Found for ADHD Meds, CVD Risk
FRIDAY, Dec. 2, 2022 -- There seems to be no statistically significant association between attention-deficit/hyperactivity disorder (ADHD) medications and cardiovascular disease (CVD) risk, according to a systematic review and meta-analysis...
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news

Skills-Training Program Beneficial for Teen Drivers With ADHD
WEDNESDAY, Nov. 30, 2022 -- A computerized skills-training program designed to reduce long glances away from the road is beneficial for teenagers with attention-deficit/hyperactivity disorder (ADHD), according to a study published online Nov. 30 in...
Source: Drugs.com - Pharma News - November 30, 2022 Category: Pharmaceuticals Source Type: news

Benzodiazepine Exposure in Pregnancy Does Not Up Risk for ADHD, Autism
WEDNESDAY, Nov. 30, 2022 -- Benzodiazepine exposure during pregnancy seems not to be associated with increased risks for development of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), according to a study published...
Source: Drugs.com - Pharma News - November 30, 2022 Category: Pharmaceuticals Source Type: news

Teens With ADHD Do Not Report Worse Quality of Life
MONDAY, Oct. 17, 2022 -- A diagnosis of attention-deficit/hyperactivity disorder (ADHD) does not appear to lower overall self-reported quality of life (QOL) among adolescents (aged 14 to 15 years), according to a study published online Oct. 13 in...
Source: Drugs.com - Pharma News - October 17, 2022 Category: Pharmaceuticals Source Type: news